-
-
-
-
-
-
-
Assertio Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Assertio Therapeutics (ASRT) Misses Q1 EPS by 9c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Assertio Therapeutics (ASRT)
-
-
-
-
-
-
-
Assertio Therapeutics (ASRT) Tops Q2 EPS by 4c ; Offers Guidance
-
-
-
-
-
-
-
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
ASSERTIO HOLDINGS, INC. (NASDAQ: ASRT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Assertio Ho
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against VNET, Assertio, Cummins, and Brooge and Encourages Investors to Contact the Firm
-
1,198,614 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

